Sodium thiosulfate (hydrogen sulfide donor) ameliorates the pancreatic and liver damage induced by cyclophosphamide and/or ionizing gamma radiation in male albino rats Article Swipe
Ashraf Kassem
,
Eman F. S. Taha
,
Azza Hassan
,
Marwa A. Ibrahim
,
Ahmed Osman
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s40360-025-01011-0
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s40360-025-01011-0
Background Radiotherapy and cyclophosphamide (CYP) treatment can adversely affect various organs, including the liver and pancreas. In addition to hepatic toxicity, CYP and/or ionizing gamma radiation (R) may impact the exocrine and endocrine functions of the pancreas. This study aims to determine whether sodium thiosulfate (STS) can protect male rats against CYP and/or R-induced damage to the pancreas and liver. Materials and methods Sixty-four rats were divided into eight groups, with STS administered for 14 days prior to CYP and/or R treatment. Enzymatic activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), as well as insulin and glucose levels, were assessed. Amylase and lipase concentrations were measured using enzyme-linked immunosorbent assay (ELISA), and malondialdehyde (MDA) levels were determined to evaluate lipid peroxidation. Glutathione content (GSH), glutathione-S-transferase (GST) activity, and reactive oxygen species (ROS) were quantified. Gene expression of extracellular signal-regulated kinase (Erk-1) and c-Jun N-terminal kinase (JNK) was analyzed using real-time quantitative polymerase chain reaction (qPCR). Histopathological examination and immunohistochemical staining with anti-nuclear factor erythroid 2-related factor 2 (anti-Nrf2) antibodies were performed. Results STS treatment increased GSH, GST, and insulin levels while reducing ROS, MDA, glucose, amylase, and lipase levels. Furthermore, the STS treatment significantly downregulated mitogen-activated protein kinases (MAPKs) such as ERK and JNK Additionally, STS administration increased Nrf2 levels in both pancreatic and hepatic tissues while minimizing pathological changes. These findings suggest that STS may hold promise as a protective agent against CYP and/or R-induced liver and pancreatic damage. Conclusion The ability of STS to enhance antioxidant defenses, reduce oxidative stress, modulate signaling pathways, and preserve tissue integrity suggests its therapeutic potential in mitigating the detrimental effects of these damaging conditions by inhibiting the MAPK, ERK, and JNK signaling pathways.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s40360-025-01011-0
- https://bmcpharmacoltoxicol.biomedcentral.com/counter/pdf/10.1186/s40360-025-01011-0
- OA Status
- gold
- References
- 73
- OpenAlex ID
- https://openalex.org/W4415654834
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415654834Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s40360-025-01011-0Digital Object Identifier
- Title
-
Sodium thiosulfate (hydrogen sulfide donor) ameliorates the pancreatic and liver damage induced by cyclophosphamide and/or ionizing gamma radiation in male albino ratsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-29Full publication date if available
- Authors
-
Ashraf Kassem, Eman F. S. Taha, Azza Hassan, Marwa A. Ibrahim, Ahmed OsmanList of authors in order
- Landing page
-
https://doi.org/10.1186/s40360-025-01011-0Publisher landing page
- PDF URL
-
https://bmcpharmacoltoxicol.biomedcentral.com/counter/pdf/10.1186/s40360-025-01011-0Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmcpharmacoltoxicol.biomedcentral.com/counter/pdf/10.1186/s40360-025-01011-0Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
73Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415654834 |
|---|---|
| doi | https://doi.org/10.1186/s40360-025-01011-0 |
| ids.doi | https://doi.org/10.1186/s40360-025-01011-0 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41163077 |
| ids.openalex | https://openalex.org/W4415654834 |
| fwci | 0.0 |
| type | article |
| title | Sodium thiosulfate (hydrogen sulfide donor) ameliorates the pancreatic and liver damage induced by cyclophosphamide and/or ionizing gamma radiation in male albino rats |
| biblio.issue | 1 |
| biblio.volume | 26 |
| biblio.last_page | 178 |
| biblio.first_page | 178 |
| is_xpac | False |
| apc_list.value | 1690 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2072 |
| apc_paid.value | 1690 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2072 |
| language | en |
| locations[0].id | doi:10.1186/s40360-025-01011-0 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S29101735 |
| locations[0].source.issn | 2050-6511 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2050-6511 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMC Pharmacology and Toxicology |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://bmcpharmacoltoxicol.biomedcentral.com/counter/pdf/10.1186/s40360-025-01011-0 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMC Pharmacology and Toxicology |
| locations[0].landing_page_url | https://doi.org/10.1186/s40360-025-01011-0 |
| locations[1].id | pmid:41163077 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMC pharmacology & toxicology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41163077 |
| locations[2].id | pmh:oai:europepmc.org:11377899 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12570452 |
| locations[3].id | pmh:oai:doaj.org/article:f145e6ca109c4a3ebb78f2d886e0e5fc |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | BMC Pharmacology and Toxicology, Vol 26, Iss 1, Pp 1-20 (2025) |
| locations[3].landing_page_url | https://doaj.org/article/f145e6ca109c4a3ebb78f2d886e0e5fc |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5110225236 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ashraf Kassem |
| authorships[0].countries | EG |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I145487455 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| authorships[0].institutions[0].id | https://openalex.org/I145487455 |
| authorships[0].institutions[0].ror | https://ror.org/03q21mh05 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I145487455 |
| authorships[0].institutions[0].country_code | EG |
| authorships[0].institutions[0].display_name | Cairo University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ashraf Kassem |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| authorships[1].author.id | https://openalex.org/A5111254047 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Eman F. S. Taha |
| authorships[1].countries | EG |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I3089115 |
| authorships[1].affiliations[0].raw_affiliation_string | Health Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt |
| authorships[1].institutions[0].id | https://openalex.org/I3089115 |
| authorships[1].institutions[0].ror | https://ror.org/04hd0yz67 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I3089115 |
| authorships[1].institutions[0].country_code | EG |
| authorships[1].institutions[0].display_name | Egyptian Atomic Energy Authority |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Eman F. S. Taha |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Health Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt |
| authorships[2].author.id | https://openalex.org/A5090013790 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5865-1549 |
| authorships[2].author.display_name | Azza Hassan |
| authorships[2].countries | EG |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I145487455 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| authorships[2].institutions[0].id | https://openalex.org/I145487455 |
| authorships[2].institutions[0].ror | https://ror.org/03q21mh05 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I145487455 |
| authorships[2].institutions[0].country_code | EG |
| authorships[2].institutions[0].display_name | Cairo University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Azza Hassan |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| authorships[3].author.id | https://openalex.org/A5071955737 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7935-8379 |
| authorships[3].author.display_name | Marwa A. Ibrahim |
| authorships[3].countries | EG |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I145487455 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| authorships[3].institutions[0].id | https://openalex.org/I145487455 |
| authorships[3].institutions[0].ror | https://ror.org/03q21mh05 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I145487455 |
| authorships[3].institutions[0].country_code | EG |
| authorships[3].institutions[0].display_name | Cairo University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Marwa A. Ibrahim |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| authorships[4].author.id | https://openalex.org/A5056418668 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9302-8608 |
| authorships[4].author.display_name | Ahmed Osman |
| authorships[4].countries | EG |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I145487455 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| authorships[4].institutions[0].id | https://openalex.org/I145487455 |
| authorships[4].institutions[0].ror | https://ror.org/03q21mh05 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I145487455 |
| authorships[4].institutions[0].country_code | EG |
| authorships[4].institutions[0].display_name | Cairo University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Ahmed H. Osman |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Al Giza, Egypt |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmcpharmacoltoxicol.biomedcentral.com/counter/pdf/10.1186/s40360-025-01011-0 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-29T00:00:00 |
| display_name | Sodium thiosulfate (hydrogen sulfide donor) ameliorates the pancreatic and liver damage induced by cyclophosphamide and/or ionizing gamma radiation in male albino rats |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1186/s40360-025-01011-0 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S29101735 |
| best_oa_location.source.issn | 2050-6511 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2050-6511 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMC Pharmacology and Toxicology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://bmcpharmacoltoxicol.biomedcentral.com/counter/pdf/10.1186/s40360-025-01011-0 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMC Pharmacology and Toxicology |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s40360-025-01011-0 |
| primary_location.id | doi:10.1186/s40360-025-01011-0 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S29101735 |
| primary_location.source.issn | 2050-6511 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2050-6511 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMC Pharmacology and Toxicology |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://bmcpharmacoltoxicol.biomedcentral.com/counter/pdf/10.1186/s40360-025-01011-0 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMC Pharmacology and Toxicology |
| primary_location.landing_page_url | https://doi.org/10.1186/s40360-025-01011-0 |
| publication_date | 2025-10-29 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W1987857240, https://openalex.org/W3190191592, https://openalex.org/W4406757252, https://openalex.org/W2108274559, https://openalex.org/W1984482968, https://openalex.org/W3213987048, https://openalex.org/W2170928125, https://openalex.org/W2959315873, https://openalex.org/W4405704301, https://openalex.org/W3172786198, https://openalex.org/W4220772221, https://openalex.org/W4402410554, https://openalex.org/W3039466527, https://openalex.org/W4386227321, https://openalex.org/W3047221362, https://openalex.org/W4406621529, https://openalex.org/W3006638055, https://openalex.org/W4281693805, https://openalex.org/W2623510617, https://openalex.org/W4247050267, https://openalex.org/W1691819044, https://openalex.org/W1982234304, https://openalex.org/W4391751170, https://openalex.org/W3128689532, https://openalex.org/W4407348768, https://openalex.org/W2402392610, https://openalex.org/W2053054955, https://openalex.org/W1982144156, https://openalex.org/W1581414347, https://openalex.org/W2904416077, https://openalex.org/W4291006323, https://openalex.org/W2086810148, https://openalex.org/W2085461619, https://openalex.org/W4282941642, https://openalex.org/W2940490146, https://openalex.org/W2087484885, https://openalex.org/W3134598794, https://openalex.org/W2884329221, https://openalex.org/W2754392425, https://openalex.org/W2091403015, https://openalex.org/W2043494185, https://openalex.org/W1965788245, https://openalex.org/W1970637557, https://openalex.org/W2232708276, https://openalex.org/W2038465524, https://openalex.org/W2893102839, https://openalex.org/W1524821074, https://openalex.org/W2115202686, https://openalex.org/W2887391240, https://openalex.org/W2156517916, https://openalex.org/W2010428310, https://openalex.org/W1972891554, https://openalex.org/W2161132047, https://openalex.org/W1995209187, https://openalex.org/W2036906474, https://openalex.org/W2043719055, https://openalex.org/W2010324404, https://openalex.org/W2988964749, https://openalex.org/W2121000910, https://openalex.org/W2139737762, https://openalex.org/W2122806379, https://openalex.org/W2104332449, https://openalex.org/W3136281240, https://openalex.org/W103869046, https://openalex.org/W3096505229, https://openalex.org/W2516459186, https://openalex.org/W3090017428, https://openalex.org/W2983091663, https://openalex.org/W4207021613, https://openalex.org/W2011057086, https://openalex.org/W2085203929, https://openalex.org/W4407186450, https://openalex.org/W2063953032 |
| referenced_works_count | 73 |
| abstract_inverted_index.2 | 168 |
| abstract_inverted_index.R | 81 |
| abstract_inverted_index.a | 231 |
| abstract_inverted_index.14 | 75 |
| abstract_inverted_index.In | 17 |
| abstract_inverted_index.as | 93, 95, 202, 230 |
| abstract_inverted_index.by | 274 |
| abstract_inverted_index.in | 212, 265 |
| abstract_inverted_index.of | 35, 85, 138, 245, 270 |
| abstract_inverted_index.to | 19, 41, 56, 78, 119, 247 |
| abstract_inverted_index.(R) | 27 |
| abstract_inverted_index.CYP | 22, 52, 79, 235 |
| abstract_inverted_index.ERK | 203 |
| abstract_inverted_index.JNK | 205, 280 |
| abstract_inverted_index.STS | 72, 174, 193, 207, 226, 246 |
| abstract_inverted_index.The | 243 |
| abstract_inverted_index.and | 3, 15, 32, 59, 62, 89, 97, 103, 113, 129, 143, 159, 179, 188, 204, 215, 239, 257, 279 |
| abstract_inverted_index.can | 7, 47 |
| abstract_inverted_index.for | 74 |
| abstract_inverted_index.its | 262 |
| abstract_inverted_index.may | 28, 227 |
| abstract_inverted_index.the | 13, 30, 36, 57, 192, 267, 276 |
| abstract_inverted_index.was | 148 |
| abstract_inverted_index.ERK, | 278 |
| abstract_inverted_index.GSH, | 177 |
| abstract_inverted_index.GST, | 178 |
| abstract_inverted_index.Gene | 136 |
| abstract_inverted_index.MDA, | 185 |
| abstract_inverted_index.Nrf2 | 210 |
| abstract_inverted_index.ROS, | 184 |
| abstract_inverted_index.This | 38 |
| abstract_inverted_index.aims | 40 |
| abstract_inverted_index.both | 213 |
| abstract_inverted_index.days | 76 |
| abstract_inverted_index.hold | 228 |
| abstract_inverted_index.into | 68 |
| abstract_inverted_index.male | 49 |
| abstract_inverted_index.rats | 50, 65 |
| abstract_inverted_index.such | 201 |
| abstract_inverted_index.that | 225 |
| abstract_inverted_index.well | 94 |
| abstract_inverted_index.were | 66, 100, 106, 117, 134, 171 |
| abstract_inverted_index.with | 71, 162 |
| abstract_inverted_index.(ALT) | 88 |
| abstract_inverted_index.(CYP) | 5 |
| abstract_inverted_index.(GST) | 127 |
| abstract_inverted_index.(JNK) | 147 |
| abstract_inverted_index.(MDA) | 115 |
| abstract_inverted_index.(ROS) | 133 |
| abstract_inverted_index.(STS) | 46 |
| abstract_inverted_index.MAPK, | 277 |
| abstract_inverted_index.These | 222 |
| abstract_inverted_index.agent | 233 |
| abstract_inverted_index.assay | 111 |
| abstract_inverted_index.c-Jun | 144 |
| abstract_inverted_index.chain | 154 |
| abstract_inverted_index.eight | 69 |
| abstract_inverted_index.gamma | 25 |
| abstract_inverted_index.lipid | 121 |
| abstract_inverted_index.liver | 14, 238 |
| abstract_inverted_index.prior | 77 |
| abstract_inverted_index.study | 39 |
| abstract_inverted_index.these | 271 |
| abstract_inverted_index.using | 108, 150 |
| abstract_inverted_index.while | 182, 218 |
| abstract_inverted_index.(AST), | 92 |
| abstract_inverted_index.(GSH), | 125 |
| abstract_inverted_index.affect | 9 |
| abstract_inverted_index.and/or | 23, 53, 80, 236 |
| abstract_inverted_index.damage | 55 |
| abstract_inverted_index.factor | 164, 167 |
| abstract_inverted_index.impact | 29 |
| abstract_inverted_index.kinase | 141, 146 |
| abstract_inverted_index.levels | 116, 181, 211 |
| abstract_inverted_index.lipase | 104, 189 |
| abstract_inverted_index.liver. | 60 |
| abstract_inverted_index.oxygen | 131 |
| abstract_inverted_index.reduce | 251 |
| abstract_inverted_index.sodium | 44 |
| abstract_inverted_index.tissue | 259 |
| abstract_inverted_index.(Erk-1) | 142 |
| abstract_inverted_index.(MAPKs) | 200 |
| abstract_inverted_index.(qPCR). | 156 |
| abstract_inverted_index.Amylase | 102 |
| abstract_inverted_index.Results | 173 |
| abstract_inverted_index.ability | 244 |
| abstract_inverted_index.against | 51, 234 |
| abstract_inverted_index.alanine | 86 |
| abstract_inverted_index.content | 124 |
| abstract_inverted_index.damage. | 241 |
| abstract_inverted_index.divided | 67 |
| abstract_inverted_index.effects | 269 |
| abstract_inverted_index.enhance | 248 |
| abstract_inverted_index.glucose | 98 |
| abstract_inverted_index.groups, | 70 |
| abstract_inverted_index.hepatic | 20, 216 |
| abstract_inverted_index.insulin | 96, 180 |
| abstract_inverted_index.kinases | 199 |
| abstract_inverted_index.levels, | 99 |
| abstract_inverted_index.levels. | 190 |
| abstract_inverted_index.methods | 63 |
| abstract_inverted_index.organs, | 11 |
| abstract_inverted_index.promise | 229 |
| abstract_inverted_index.protect | 48 |
| abstract_inverted_index.protein | 198 |
| abstract_inverted_index.species | 132 |
| abstract_inverted_index.stress, | 253 |
| abstract_inverted_index.suggest | 224 |
| abstract_inverted_index.tissues | 217 |
| abstract_inverted_index.various | 10 |
| abstract_inverted_index.whether | 43 |
| abstract_inverted_index.(ELISA), | 112 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.addition | 18 |
| abstract_inverted_index.amylase, | 187 |
| abstract_inverted_index.analyzed | 149 |
| abstract_inverted_index.changes. | 221 |
| abstract_inverted_index.damaging | 272 |
| abstract_inverted_index.evaluate | 120 |
| abstract_inverted_index.exocrine | 31 |
| abstract_inverted_index.findings | 223 |
| abstract_inverted_index.glucose, | 186 |
| abstract_inverted_index.ionizing | 24 |
| abstract_inverted_index.measured | 107 |
| abstract_inverted_index.modulate | 254 |
| abstract_inverted_index.pancreas | 58 |
| abstract_inverted_index.preserve | 258 |
| abstract_inverted_index.reaction | 155 |
| abstract_inverted_index.reactive | 130 |
| abstract_inverted_index.reducing | 183 |
| abstract_inverted_index.staining | 161 |
| abstract_inverted_index.suggests | 261 |
| abstract_inverted_index.2-related | 166 |
| abstract_inverted_index.Enzymatic | 83 |
| abstract_inverted_index.Materials | 61 |
| abstract_inverted_index.R-induced | 54, 237 |
| abstract_inverted_index.activity, | 128 |
| abstract_inverted_index.adversely | 8 |
| abstract_inverted_index.aspartate | 90 |
| abstract_inverted_index.assessed. | 101 |
| abstract_inverted_index.defenses, | 250 |
| abstract_inverted_index.determine | 42 |
| abstract_inverted_index.endocrine | 33 |
| abstract_inverted_index.erythroid | 165 |
| abstract_inverted_index.functions | 34 |
| abstract_inverted_index.including | 12 |
| abstract_inverted_index.increased | 176, 209 |
| abstract_inverted_index.integrity | 260 |
| abstract_inverted_index.oxidative | 252 |
| abstract_inverted_index.pancreas. | 16, 37 |
| abstract_inverted_index.pathways, | 256 |
| abstract_inverted_index.pathways. | 282 |
| abstract_inverted_index.potential | 264 |
| abstract_inverted_index.radiation | 26 |
| abstract_inverted_index.real-time | 151 |
| abstract_inverted_index.signaling | 255, 281 |
| abstract_inverted_index.toxicity, | 21 |
| abstract_inverted_index.treatment | 6, 175, 194 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 242 |
| abstract_inverted_index.N-terminal | 145 |
| abstract_inverted_index.Sixty-four | 64 |
| abstract_inverted_index.activities | 84 |
| abstract_inverted_index.antibodies | 170 |
| abstract_inverted_index.conditions | 273 |
| abstract_inverted_index.determined | 118 |
| abstract_inverted_index.expression | 137 |
| abstract_inverted_index.inhibiting | 275 |
| abstract_inverted_index.minimizing | 219 |
| abstract_inverted_index.mitigating | 266 |
| abstract_inverted_index.pancreatic | 214, 240 |
| abstract_inverted_index.performed. | 172 |
| abstract_inverted_index.polymerase | 153 |
| abstract_inverted_index.protective | 232 |
| abstract_inverted_index.treatment. | 82 |
| abstract_inverted_index.(anti-Nrf2) | 169 |
| abstract_inverted_index.Glutathione | 123 |
| abstract_inverted_index.antioxidant | 249 |
| abstract_inverted_index.detrimental | 268 |
| abstract_inverted_index.examination | 158 |
| abstract_inverted_index.quantified. | 135 |
| abstract_inverted_index.therapeutic | 263 |
| abstract_inverted_index.thiosulfate | 45 |
| abstract_inverted_index.Furthermore, | 191 |
| abstract_inverted_index.Radiotherapy | 2 |
| abstract_inverted_index.administered | 73 |
| abstract_inverted_index.anti-nuclear | 163 |
| abstract_inverted_index.pathological | 220 |
| abstract_inverted_index.quantitative | 152 |
| abstract_inverted_index.Additionally, | 206 |
| abstract_inverted_index.downregulated | 196 |
| abstract_inverted_index.enzyme-linked | 109 |
| abstract_inverted_index.extracellular | 139 |
| abstract_inverted_index.immunosorbent | 110 |
| abstract_inverted_index.peroxidation. | 122 |
| abstract_inverted_index.significantly | 195 |
| abstract_inverted_index.administration | 208 |
| abstract_inverted_index.concentrations | 105 |
| abstract_inverted_index.malondialdehyde | 114 |
| abstract_inverted_index.aminotransferase | 87, 91 |
| abstract_inverted_index.cyclophosphamide | 4 |
| abstract_inverted_index.signal-regulated | 140 |
| abstract_inverted_index.Histopathological | 157 |
| abstract_inverted_index.mitogen-activated | 197 |
| abstract_inverted_index.immunohistochemical | 160 |
| abstract_inverted_index.glutathione-S-transferase | 126 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5111254047 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I3089115 |
| citation_normalized_percentile |